Status:
NOT_YET_RECRUITING
Efficacy and Safety of Robot-assisted Endoscopic Submucosal Dissection for Colorectal Neoplasm
Lead Sponsor:
Shandong University
Conditions:
Robot Surgery
Endoscopic Submucosal Dissection (ESD)
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The objective of this study is to investigate the role of the flexible auxiliary single-arm transluminal endoscopic robot (FASTER) system in colorectal endoscopic submucosal dissection (ESD) and to va...
Eligibility Criteria
Inclusion
- Patients aged 18-85.
- Patients with pathologically verified colorectal neoplasms scheduled to undergo ESD.
Exclusion
- Patients have lesions with confirmed or potential deep submucosal invasion or lymph node metastasis or other conditions that are not suitable for endoscopic therapy.
- Patients with severe underlying diseases precluding endotracheal intubation, general anesthesia, or surgery.
- Patients have a history of colorectal malignancy with previous radiotherapy or operative treatment leading to changes in colorectal structure.
- Patients have lesions with local recurrence after endoscopic resection.
- Patients unable to obtain informed consent.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06973083
Start Date
June 1 2025
End Date
December 30 2026
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012